scispace - formally typeset
M

Meenakshi A. Chellaiah

Researcher at University of Maryland, Baltimore

Publications -  42
Citations -  3342

Meenakshi A. Chellaiah is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Osteoclast & Osteopontin. The author has an hindex of 32, co-authored 41 publications receiving 3007 citations. Previous affiliations of Meenakshi A. Chellaiah include University of Maryland, College Park & Washington University in St. Louis.

Papers
More filters
Journal ArticleDOI

CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells.

TL;DR: Recent observations have shown that CD44 intracellular domain (CD44-ICD) is related to the metastatic potential of breast cancer cells, however, the underlying mechanisms need further elucidation.
Journal ArticleDOI

Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength

TL;DR: It is demonstrated that gelsolin deficiency blocks podosome assembly and αvβ3-stimulated signaling related to motility in gelolin-null mice, demonstrating the critical role of gelsolins in podosomes assembly, rapid cell movements, and signal transduction through the αv β3 integrin.
Journal ArticleDOI

Rho-A is critical for osteoclast podosome organization, motility, and bone resorption.

TL;DR: It is demonstrated that integrin-dependent activation of phosphoinositide synthesis, actin stress fiber formation, podosome reorganization for osteoclast motility, and bone resorption require Rho stimulation.
Journal ArticleDOI

Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells

TL;DR: It is suggested that CD44 surface expression is an important event in the activation of MMP-9 and migration of prostate cancer cells and the various steps involved in the above mentioned signaling pathway and/or the molecules regulating the activated molecule are potential therapeutic target.